167 related articles for article (PubMed ID: 20978891)
1. Long-term angiographic outcomes of post-sirolimus-eluting stent restenosis in Japanese patients.
Miyai N; Kinoshita N; Oota K; Yamada T; Nakamura R; Irie H; Hashimoto T; Tamaki S; Matsubara H
Heart Vessels; 2011 Mar; 26(2):168-75. PubMed ID: 20978891
[TBL] [Abstract][Full Text] [Related]
2. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
[TBL] [Abstract][Full Text] [Related]
3. Repeated sirolimus-eluting stent implantation to treat sirolimus-eluting stent and bare-metal stent restenosis.
Nishihira K; Shibata Y; Ishikawa T; Nomura K; Nakama T; Mine D; Inoue Y; Ashikaga K; Kuriyama N; Matsuyama A; Imamura T; Asada Y; Kitamura K
Circ J; 2010 Nov; 74(11):2329-33. PubMed ID: 20890050
[TBL] [Abstract][Full Text] [Related]
4. Late restenosis following sirolimus-eluting stent implantation.
Kuriyama N; Kobayashi Y; Nakama T; Mine D; Nishihira K; Shimomura M; Nomura K; Ashikaga K; Matsuyama A; Shibata Y
JACC Cardiovasc Interv; 2011 Jan; 4(1):123-8. PubMed ID: 21251639
[TBL] [Abstract][Full Text] [Related]
5. Third in-stent restenosis in sirolimus eluting stents: predictors of the next restenosis.
Ozawa M; Okamura A; Date M; Higuchi Y; Nagai H; Shibuya M; Ryusuke K; Inoue K; Koyama Y; Iwakura K; Fujii K
Catheter Cardiovasc Interv; 2012 Jan; 79(1):91-6. PubMed ID: 21452246
[TBL] [Abstract][Full Text] [Related]
6. Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: results of long-term follow-up.
Freixa X; Almasood AS; Khan SQ; Wainstein R; Osherov A; Mackie K; Seidelin PH; Džavík V
Catheter Cardiovasc Interv; 2012 Mar; 79(4):559-65. PubMed ID: 21567881
[TBL] [Abstract][Full Text] [Related]
7. Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON).
Rozenman Y; Witzling V; Tamari I; Turkisher V; Kriviski M; Bode C; Henry P; Teiger E; Cebrian A; Stoll HP; Spaulding C
EuroIntervention; 2009 Jun; 5(2):219-23. PubMed ID: 19527979
[TBL] [Abstract][Full Text] [Related]
8. Re-restenosis and target lesion revascularization after treatment of sirolimus-eluting stent restenosis: retrospective analysis of 4 Japanese hospitals.
Kitahara H; Kobayashi Y; Takebayashi H; Fujimoto Y; Nakamura Y; Kuroda N; Himi T; Miyazaki A; Haruta S; Komuro I
Circ J; 2009 May; 73(5):867-71. PubMed ID: 19359815
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.
Chen J; Li JJ; Chen JL; Qiao SB; Xu B; Yang YJ; Gao RL; Qin XW; Yuan JQ; Yao M; Wu YJ; Liu HB; Dai J; You SJ
Coron Artery Dis; 2008 Nov; 19(7):507-11. PubMed ID: 18923247
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.
Ota H; Mahmoudi M; Kitabata H; Torguson R; Chen F; Satler LF; Suddath WO; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2015 Mar; 16(2):84-9. PubMed ID: 25870152
[TBL] [Abstract][Full Text] [Related]
11. Significant association of coronary stent fracture with in-stent restenosis in sirolimus-eluting stents.
Kim JS; Lee SY; Lee JM; Yoon YW; Ahn CM; Kim MH; Min PK; Ko YG; Hong BK; Choi D; Kwon HM; Jang Y; Shim WH
Coron Artery Dis; 2009 Jan; 20(1):59-63. PubMed ID: 19008765
[TBL] [Abstract][Full Text] [Related]
12. Impact of lesion calcification on clinical and angiographic outcome after sirolimus-eluting stent implantation in real-world patients.
Kawaguchi R; Tsurugaya H; Hoshizaki H; Toyama T; Oshima S; Taniguchi K
Cardiovasc Revasc Med; 2008; 9(1):2-8. PubMed ID: 18206630
[TBL] [Abstract][Full Text] [Related]
13. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
Novack V; Cutlip D; Kleiman N; Pencina M; Mauri L; Yen CH; Berger P; Goldberg S; Kellett M; Waksman R; Hong M; Raizner AE; Cohen DJ
JACC Cardiovasc Interv; 2009 Aug; 2(8):767-75. PubMed ID: 19695546
[TBL] [Abstract][Full Text] [Related]
14. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB
JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327
[TBL] [Abstract][Full Text] [Related]
15. Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy.
Wykrzykowska JJ; Serruys PW; Onuma Y; de Vries T; van Es GA; Buszman P; Linke A; Ischinger T; Klauss V; Corti R; Eberli F; Wijns W; Morice MC; di Mario C; van Geuns RJ; Juni P; Windecker S
JACC Cardiovasc Interv; 2009 Sep; 2(9):861-70. PubMed ID: 19778775
[TBL] [Abstract][Full Text] [Related]
16. Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy.
Wykrzykowska JJ; Räber L; de Vries T; Bressers M; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Corti R; Wijns W; Morice MC; di Mario C; Regar E; Jüni P; Windecker S; Serruys PW
EuroIntervention; 2009 Aug; 5(3):310-7. PubMed ID: 19736154
[TBL] [Abstract][Full Text] [Related]
17. Utility of myocardial fractional flow reserve for prediction of restenosis following sirolimus-eluting stent implantation.
Ishii H; Kataoka T; Kobayashi Y; Tsumori T; Takeshita H; Matsumoto R; Shirai N; Nishioka H; Hasegawa T; Nakata S; Shimada Y; Ehara S; Muro T; Yoshiyama M
Heart Vessels; 2011 Nov; 26(6):572-81. PubMed ID: 21221600
[TBL] [Abstract][Full Text] [Related]
18. Do drug elution components increase the risk of fracture of sirolimus-eluting stents?
Kawai T; Umeda H; Ota M; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Naruse H; Matsui S; Ishii J; Hishida H; Ozaki Y
Coron Artery Dis; 2010 Aug; 21(5):298-303. PubMed ID: 20617542
[TBL] [Abstract][Full Text] [Related]
19. Stent fracture, an incidental finding or a significant marker of clinical in-stent restenosis?
Shaikh F; Maddikunta R; Djelmami-Hani M; Solis J; Allaqaband S; Bajwa T
Catheter Cardiovasc Interv; 2008 Apr; 71(5):614-8. PubMed ID: 18360853
[TBL] [Abstract][Full Text] [Related]
20. Angiographic restenosis and clinical recurrence after sirolimus- and paclitaxel-eluting stent implantation.
Vlaar PJ; Zijlstra F
JACC Cardiovasc Interv; 2009 Aug; 2(8):776-8. PubMed ID: 19695547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
